News

The House of Lords has backed a move to block the expulsion of hereditary peers from the upper chamber. Peers supported by ...
The House of Lords has tried to block Labour’s ban on hereditary peers. On Wednesday, Peers backed an amendment to Labour’s ...
Melanin can either protect or worsen hereditary hearing loss depending on genetic context, as reported by researchers from ...
Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the best CRISPR stocks to buy. Citizens JMP reaffirmed its Market ...
The House of Lords (hereditary peers) bill does one simple thing: remove the remaining hereditary peers from membership of ...
Tempus AI Inc. (NASDAQ:TEM) is one of the best AI stocks to buy according to hedge funds. On June 25, Ambry Genetics, which is a wholly owned subsidiary of Tempus AI, announced the publication of ...
Using 400 real-world patient cases, the CARE platform correctly classified 99.5 percent of cases according to NCCN guidelines ...
The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa ...
Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.
The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years ...
BioCryst on Friday said it will receive an initial $250 million from Italian pharmaceutical company Neopharmed Gentili for the European assets and rights related to Orladeyo, along with up to $14 ...